Procyrion announced today that it appointed Andrew Davis as its new chief commercial officer (CCO), effective immediately.
HOUSTON, Dec. 2, 2025 /PRNewswire/ -- Procyrion (TM), Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the appointment of ...
Blood Volume Profiles and Correlations with Pressures in Heart Failure with Impaired Renal Function Receive the the latest news, research, and presentations from major meetings right to your inbox.
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
In this paper, we review the information accumulated over the years regarding the phenomena of resetting and entrainment of reentrant arrhythmias. Over three decades of research and clinical ...